LifeMD, Inc. (LFMD)
Nasdaq · Services-Offices & Clinics Of Doctors Of Medicine · Services · CIK 948320 · fiscal year ends in Dec
Closing price $2.30 on 30 Oct 2026; 52-week range $2.08 to $5.91.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Market value
- $110.0M
- Cash
- $25.1M
- Debt
- $0
- Debt to equity
- 0.00
- Shares outstanding
- 47.8M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $194.1M | -$7.7M | $14.4M | $0.25 | $6.4M | 10-K filed 10 Mar 2026 |
| FY2024 | 31 Dec 2024 | $154.8M | -$20.4M | -$21.4M | -$0.60 | $16.0M | 10-K filed 11 Mar 2025 |
| FY2023 | 31 Dec 2023 | $152.5M | -$14.5M | -$20.6M | – | $8.6M | 10-K filed 11 Mar 2024 |
| FY2022 | 31 Dec 2022 | $119.0M | -$43.4M | -$45.5M | – | -$23.3M | 10-K filed 22 Mar 2023 |
| FY2021 | 31 Dec 2021 | $92.9M | -$54.3M | -$60.9M | -$2.29 | -$33.3M | 10-K filed 7 Mar 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $47.3M | -$7.1M | -$0.16 |
| Q1 FY2026 | 31 Mar 2026 | $50.2M | -$8.9M | -$0.20 |
| Q4 FY2025 | 31 Dec 2025 | – | – | – |
| Q3 FY2025 | 30 Sep 2025 | $60.2M | -$3.8M | – |
| Q2 FY2025 | 30 Jun 2025 | $49.0M | -$1.6M | -$0.05 |
| Q1 FY2025 | 31 Mar 2025 | $50.9M | -$183.8K | -$0.02 |
| Q4 FY2024 | 31 Dec 2024 | $64.3M | -$106.3K | -$0.02 |
| Q3 FY2024 | 30 Sep 2024 | $53.3M | -$4.7M | -$0.13 |
Company events
The newest 8-K filings of 143 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 15 Sep 2026 | 8-K | Investor update | 7.01, 9.01 |
| 5 Aug 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 22 Jun 2026 | 8-K | Investor update | 7.01, 9.01 |
| 6 May 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 18 Mar 2026 | 8-K | Leadership change, Other events | 5.02, 8.01, 9.01 |
| 9 Mar 2026 | 8-K | Results, Investor update | 2.02, 7.01, 9.01 |
| 6 Jan 2026 | 8-K | Material agreement, New debt, Investor update | 1.01, 2.03, 7.01, 9.01 |
| 17 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 5 Nov 2025 | 8-K | Investor update | 7.01, 9.01 |
| 4 Nov 2025 | 8-K | Deal completed, Material agreement, Investor update | 1.01, 2.01, 7.01, 9.01 |
| 21 Aug 2025 | 8-K | Auditor change | 4.01, 9.01 |
| 5 Aug 2025 | 8-K | Results | 2.02, 9.01 |
Every filing
The newest filings with the SEC of 313 held.
| Filed | Form | Period |
|---|---|---|
| 25 Sep 2026 | S-8 | – |
| 15 Sep 2026 | 8-K | 15 Sep 2026 |
| 5 Aug 2026 | 10-Q | 30 Jun 2026 |
| 5 Aug 2026 | 8-K | 5 Aug 2026 |
| 22 Jun 2026 | 8-K | 22 Jun 2026 |
| 6 May 2026 | 10-Q | 31 Mar 2026 |
| 6 May 2026 | 8-K | 6 May 2026 |
| 30 Apr 2026 | ARS | 31 Dec 2025 |
| 30 Apr 2026 | DEFA14A | – |
| 30 Apr 2026 | DEFA14A | – |
| 30 Apr 2026 | DEF 14A | 30 Apr 2026 |
| 1 Apr 2026 | S-8 | – |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 9 Dec 2025 | Friedeman Jessica, Chief Marketing Officer | Sale outside a trading plan | 15,000 | $3.61 | $54.2K | 205,000 | 11 Dec 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 23 Mar 2026 | FRIEDEMAN JESSICA, Officer | 40,000 | $185.7K | 23 Mar 2026 |
| 24 Nov 2025 | FRIEDEMAN JESSICA, Officer | 20,000 | $80.8K | 24 Nov 2025 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 7 Oct 2026 | Federated Hermes, Inc. | 13G amended | 8.4% | 4.0M |
| 8 Jul 2026 | Federated Hermes, Inc. | 13G | 5.68% | 2.7M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 7.4M | -2.1% | 11.03 |
| 30 Sep 2026 | 7.6M | +2.18% | 10.36 |
| 15 Sep 2026 | 7.4M | +2.15% | 7.52 |
| 31 Aug 2026 | 7.2M | +4.21% | 14.76 |
| 14 Aug 2026 | 6.9M | -8.23% | 4.74 |
| 31 Jul 2026 | 7.6M | +6.23% | 9.72 |
| 15 Jul 2026 | 7.1M | +11.38% | 8.64 |
| 30 Jun 2026 | 6.4M | +9.02% | 5.68 |
Funds that hold it
From each fund's latest Form 13F.
126 funds held it at 30 Jun 2026: 69 added and 25 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 3,034,535 | $12.5M | +225,510 |
| Federated Hermes, Inc. | 2,747,655 | $11.3M | +1,728,578 |
| Vanguard Capital Management LLC | 1,734,756 | $7.2M | +71,060 |
| State Street Corp. | 1,318,784 | $5.4M | +243,376 |
| Renaissance Technologies LLC | 1,079,525 | $4.5M | -38,800 |
| Geode Capital Management, LLC | 1,067,698 | $4.4M | +48,257 |
| Prescott Group Capital Management, L.L.C. | 897,224 | $3.7M | +1,800 |
| BRC Group Holdings, Inc. | 637,319 | $2.6M | -234,261 |
| Royce & Associates LP | 636,124 | $2.6M | -565,527 |
| AQR Capital Management LLC | 619,506 | $2.6M | +421,184 |
Peers
Companies in the same industry.
- Hims & Hers Health, Inc. (HIMS): revenue $2.6B, market value $6.5B
- Teladoc Health, Inc. (TDOC): revenue $2.5B, market value $1.6B
- Starling Oncology, Inc. (STLN): revenue $587.2M, market value $655.6M
- SBC Medical Group Holdings Inc. (SBC): revenue $175.2M, market value $541.1M
- Airsculpt Technologies, Inc. (AIRS): revenue $150.7M, market value $123.0M